|
|
|
|
What’s Ailing Personalized Medicine?
|
|
The Platform Diet
The Platform Diet Systems Pathology for the 21st Century 2005 Pharma Achievement Award Finalists Announced Thursday, May 12, 2005 Archives Bio-IT World News Bulletin Subscribe Advertising Ema
|
|
Toward a Predictive Model for a Cell
|
|
Seven New Cholesterol Genes Discovered
|
|
What Next for Vytorin?
|
|
Some Immature Brain Cells May Promote Tumors
|
|
Team Finds 118 Genes That Might Play Role in Cancer
|
|
Stem Cell Technique Wins U.S. Funding, Fuels Debate
|
|
UI Researchers Develop Faster, Cheaper DNA Sequencing
|
|
Synthetic DNA on the Brink of Yielding New Life Forms
|
|
This Bio•IT World Briefing On “Next-Generation Sequencing,” underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data. Download now
|
SGI's Meeting Today’s Computational Needs for Science
The quest to better understand disease mechanisms and find new treatments is driven by new laboratory technologies and ever-more sophisticated modeling and simulation efforts. As such, life sciences R&D investigations increasingly are relying on more powerful computing resources. The challenge is how to accommodate the broad mix of applications.
Addressing this issue, this paper produced by the Bio-IT World Custom Publishing Group discusses a new SGI Hybrid Computing Environment approach. It optimally uses shared memory systems, multi-processor clusters, and FPGAs to accelerate computational workflows.
| | 
SGI's Supercharging Proteomics Discovery
The deeper study of proteins and their interactions can reveal scientific information once considered nearly untouchable to scientists and researchers. Today, unprecedented advancements in computing power are enabling the creation of mounds of proteomic based data along with the accompanying bottlenecks data can create.
Rather than just “simplify the experiment” to fit the computational resources an alternative is now available with the SGI Proteomics Appliance. This complimentary white paper, produced by the Bio-IT World Custom Publishing Group, looks at ways to use the Proteomic Appliance to handle the most intensive proteomics computing tasks facing science today.
|
Trade Commission of Spain
Spain’s Emerging Biotech Revolution
The biotechnology sector is growing 10 percent faster in Spain than it is in the U.S. Driven by a culture, government and private sector that are open-minded and optimistic, Spain-based companies are emerging as leaders in this dynamic field. Discover how your business can capitalize on creative solutions from Spain-based enterprises by learning about:
- Trends and factors driving the growth of Spain’s biotechnology sector.
- The Spanish government’s aggressive policies and incentive programs for biotechnology research.
- Biotechnology spin-offs, bio-clusters and new research centers in Spain that are combining entrepreneurial spirit with larger-than-ever resources.
- The strength of Spain’s biomedicine community, and how U.S. pharmaceutical companies are capitalizing on it.
Download Now
More Podcasts
Friedrich Miescher Institute for Biomedical Research - Part of the Novartis Research Foundation
Basel, Switzerland is looking for a Head of IT Systems & Infrastructure. You will manage a cutting-edge core server and network infrastructure, comprising Linux and Solaris, as well as a robust Windows and Macintosh environment. We look forward to receiving your application: [email protected]. click for more information Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD
|
|
|